Cover
Cover | Nov. 24, 2021 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment amends the Current Report on Form 8-K that Predictive Oncology Inc. (“Predictive” or the “Company”) filed with the Securities and Exchange Commission on December 1, 2021, concerning the November 24, 2021 completion of the merger of a subsidiary of the Company (the “Merger Sub”), with and into zPredicta, Inc. (“zPredicta”), pursuant to the Agreement and Plan of Merger among the Company, Merger Sub, zPredicta and a representative for certain parties who held interests in zPredicta. This Amendment includes certain historical financial information for zPredicta and certain pro forma financial information for the Company, as described in Item 9.01. |
Document Period End Date | Nov. 24, 2021 |
Entity File Number | 001-36790 |
Entity Registrant Name | Predictive Oncology Inc. |
Entity Central Index Key | 0001446159 |
Entity Tax Identification Number | 33-1007393 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 2915 Commers Drive |
Entity Address, Address Line Two | Suite 900 |
Entity Address, City or Town | Eagan |
Entity Address, State or Province | MN |
Entity Address, Postal Zip Code | 55121 |
City Area Code | (651) |
Local Phone Number | 389-4800 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, $0.01 par value |
Trading Symbol | POAI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |